MedTrace Logo

Endocan Biomarker Level in Gingival Crevicular Fluid in Periodontitis Patients With Type 2 Diabetes Mellitus

NCT05667051 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2022-12-28

No results posted yet for this study

Summary

Aim of the current study was to evaluate Endocan biomarker level in gingival crevicular fluid of patients with stage 1 or 2 (mild to moderate) periodontitis with controlled type 2 diabetes mellitus (DM) and compare it to that in DM free periodontitis patients.

Conditions

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Emad Ayyad, BDS · Faculty of Dentistry, Alexandria University, Egypt

  • Maha Abou Khadr, PhD · Faculty of Dentistry, Alexandria University, Egypt

  • Mona Ayyad, PhD · Faculty of Medicine, Alexandria University, Egypt

  • Gillan El-Kimary, PhD · Faculty of Dentistry, Alexandria University, Egypt

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-05
Primary Completion
2022-09-01
Completion
2022-09-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05667051 on ClinicalTrials.gov